SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-067368
Filing Date
2023-12-01
Accepted
2023-12-01 16:33:49
Documents
14
Period of Report
2023-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amam-20231201.htm   iXBRL 8-K 48551
2 EX-10.1 amam-ex10_1.htm EX-10.1 128201
  Complete submission text file 0000950170-23-067368.txt   349327

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amam-20231201_pre.xml EX-101.PRE 14510
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amam-20231201_def.xml EX-101.DEF 14450
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amam-20231201_lab.xml EX-101.LAB 19777
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amam-20231201.xsd EX-101.SCH 3707
8 EXTRACTED XBRL INSTANCE DOCUMENT amam-20231201_htm.xml XML 4709
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56600 | Film No.: 231460027
SIC: 2836 Biological Products, (No Diagnostic Substances)